Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice

Little observational data exist describing telbivudine (LdT) or lamivudine (LAM) use in late pregnancy for preventing hepatitis B mother-to-child transmission (MTCT) in real-world settings. During the period of January 2009 to March 2011, we enrolled hepatitis B e antigen–positive mothers with HBV D...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hua, Pan, Calvin Q, Pang, Qiumei, Tian, Ruihua, Yan, Miaoe, Liu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282428/
https://www.ncbi.nlm.nih.gov/pubmed/25187919
http://dx.doi.org/10.1002/hep.27034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282428/
https://www.ncbi.nlm.nih.gov/pubmed/25187919
http://dx.doi.org/10.1002/hep.27034

Ejemplares similares